These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

195 related items for PubMed ID: 15506047

  • 1. [Botulinum toxin type A treatment of upper limb spasticity].
    Wissel M, Wissel J.
    Wien Klin Wochenschr; 2001; 113 Suppl 4():16-9. PubMed ID: 15506047
    [Abstract] [Full Text] [Related]

  • 2. [Botulinum toxin treatment of hip adductor spasticity in multiple sclerosis].
    Wissel J, Entner T.
    Wien Klin Wochenschr; 2001; 113 Suppl 4():20-4. PubMed ID: 15506048
    [Abstract] [Full Text] [Related]

  • 3. The lowest effective dose of botulinum A toxin in adult patients with upper limb spasticity.
    Suputtitada A, Suwanwela NC.
    Disabil Rehabil; 2005 Feb 18; 27(4):176-84. PubMed ID: 15824048
    [Abstract] [Full Text] [Related]

  • 4. [Treatment of focal upper limb spasticity with botulinum toxin after stroke. Interest of an individual approach].
    Luauté J, Landrault E, Jacquin-Courtois S, Mertens P, Rode G, Boisson D.
    Ann Readapt Med Phys; 2004 Oct 18; 47(8):555-62. PubMed ID: 15465160
    [Abstract] [Full Text] [Related]

  • 5. [Treatment of the spastic drop foot with botulinum toxin type A in adult patients].
    Voller B, Földy D, Hefter H, Auff E, Schnider P.
    Wien Klin Wochenschr; 2001 Oct 18; 113 Suppl 4():25-9. PubMed ID: 15506049
    [Abstract] [Full Text] [Related]

  • 6. Botulinum toxin type A for upper limb spasticity following stroke: an open-label study with individualised, flexible injection regimens.
    Slawek J, Bogucki A, Reclawowicz D.
    Neurol Sci; 2005 Apr 18; 26(1):32-9. PubMed ID: 15877185
    [Abstract] [Full Text] [Related]

  • 7. Serial injection of botulinum toxin for muscle imbalance due to regional spasticity in the upper limb.
    Turner-Stokes L, Ashford S.
    Disabil Rehabil; 2007 Dec 15; 29(23):1806-12. PubMed ID: 18033605
    [Abstract] [Full Text] [Related]

  • 8. Management of shoulder and proximal upper limb spasticity using botulinum toxin and concurrent therapy interventions: a preliminary analysis of goals and outcomes.
    Ashford S, Turner-Stokes L.
    Disabil Rehabil; 2009 Dec 15; 31(3):220-6. PubMed ID: 18608366
    [Abstract] [Full Text] [Related]

  • 9. Repeated treatments with botulinum toxin type a produce sustained decreases in the limitations associated with focal upper-limb poststroke spasticity for caregivers and patients.
    Elovic EP, Brashear A, Kaelin D, Liu J, Millis SR, Barron R, Turkel C.
    Arch Phys Med Rehabil; 2008 May 15; 89(5):799-806. PubMed ID: 18452724
    [Abstract] [Full Text] [Related]

  • 10. [Measuring outcome in spasticity rehabilitation].
    Fheodoroff K, Wissel J, Entner T, Freimüller M.
    Wien Klin Wochenschr; 2001 May 15; 113 Suppl 4():11-5. PubMed ID: 15506046
    [Abstract] [Full Text] [Related]

  • 11. Formation of neutralizing antibodies in patients receiving botulinum toxin type A for treatment of poststroke spasticity: a pooled-data analysis of three clinical trials.
    Yablon SA, Brashear A, Gordon MF, Elovic EP, Turkel CC, Daggett S, Liu J, Brin MF.
    Clin Ther; 2007 Apr 15; 29(4):683-90. PubMed ID: 17617291
    [Abstract] [Full Text] [Related]

  • 12. [Botulinum toxin type A in the treatment plan for cerebral palsy].
    Strobl W.
    Wien Klin Wochenschr; 2001 Apr 15; 113 Suppl 4():30-5. PubMed ID: 15506050
    [Abstract] [Full Text] [Related]

  • 13. [Safety and tolerance of single-dose botulinum toxin Type A treatment in 204 patients with spasticity and localized associated symptoms. Austrian and German botulinum toxin A spasticity study group].
    Wissel J, Müller J, Heinen F, Mall V, Sojer M, Ebersbach G, Poewe W.
    Wien Klin Wochenschr; 1999 Oct 29; 111(20):837-42. PubMed ID: 10586488
    [Abstract] [Full Text] [Related]

  • 14. [Botulinum toxin: a new dimension for spasticity].
    Reichel G.
    MMW Fortschr Med; 2007 May 21; 149 Suppl 2():65-9. PubMed ID: 17724971
    [Abstract] [Full Text] [Related]

  • 15. [Treatment of spasticity with injections of botulinum toxin. Review of the literature].
    Fève A, Decq P, Filipetti P, Kéravel Y.
    Neurochirurgie; 1998 Sep 21; 44(3):192-6. PubMed ID: 9827435
    [Abstract] [Full Text] [Related]

  • 16. Can botulinum toxin decrease carer burden in long term care residents with upper limb spasticity? A randomized controlled study.
    Lam K, Lau KK, So KK, Tam CK, Wu YM, Cheung G, Liang KS, Yeung KM, Lam KY, Yui S, Leung C.
    J Am Med Dir Assoc; 2012 Jun 21; 13(5):477-84. PubMed ID: 22521630
    [Abstract] [Full Text] [Related]

  • 17. Comparative impact of 2 botulinum toxin injection techniques for elbow flexor hypertonia.
    Mayer NH, Whyte J, Wannstedt G, Ellis CA.
    Arch Phys Med Rehabil; 2008 May 21; 89(5):982-7. PubMed ID: 18452749
    [Abstract] [Full Text] [Related]

  • 18. Efficacy and safety of treatment with incobotulinum toxin A (botulinum neurotoxin type A free from complexing proteins; NT 201) in post-stroke upper limb spasticity.
    Kaňovský P, Slawek J, Denes Z, Platz T, Comes G, Grafe S, Pulte I.
    J Rehabil Med; 2011 May 21; 43(6):486-92. PubMed ID: 21533328
    [Abstract] [Full Text] [Related]

  • 19. Efficacy and safety of botulinum toxin type A (Dysport) for the treatment of post-stroke arm spasticity: results of the German-Austrian open-label post-marketing surveillance prospective study.
    Jost WH, Hefter H, Reissig A, Kollewe K, Wissel J.
    J Neurol Sci; 2014 Feb 15; 337(1-2):86-90. PubMed ID: 24361062
    [Abstract] [Full Text] [Related]

  • 20. Management of spasticity and dystonia in children with acquired brain injury with rehabilitation and botulinum toxin A.
    Guettard E, Roze E, Abada G, Lemesle C, Vidailhet M, Laurent-Vannier A, Chevignard MP.
    Dev Neurorehabil; 2009 Jun 15; 12(3):128-38. PubMed ID: 19466620
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.